Patents by Inventor Donald A. Kaplan

Donald A. Kaplan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240289150
    Abstract: A processor includes a security processor and an input-output memory management unit (IOMMU). The security processor is configured to maintain device control information in a secure data structure and prevent a hypervisor from accessing the secure data structure. The IOMMU is configured to process at least one device request targeting a virtual machine from an input/output device based on the secure data structure.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 29, 2024
    Inventors: Philip Ng, Nippon Raval, Jeremy W. Powell, Donald Matthews, JR., David Kaplan
  • Publication number: 20240289151
    Abstract: A processor configured to execute one or more virtual machines (VMs) includes an input-output memory management unit (IOMMU) configured to handle memory-mapped input-output (MMIO) requests and direct memory access (DMA) requests from a processor core of the processor or one or more input/output (I/O) devices. In response to receiving an MMIO or DMA request, the IOMMU is configured to determine a VM associated with the request. The IOMMU then checks a security indicator field of an address space identifier (ASID) mask table to determine if the VM was previously the target of an attack by a malicious entity. In response to the VM previously being a target of an attack, the IOMMU denies the received MMIO or DMA request.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 29, 2024
    Inventors: Philip Ng, Nippon Raval, Jeremy W. Powell, Donald Matthews, JR., David Kaplan
  • Patent number: 7389244
    Abstract: A method and system for providing travel services are disclosed. The method and system include a database of travel information from which information can be selectively obtained based on the traveler's circumstances. The method and system also include a system for providing counseling services and an emergency kit containing food, water and other supplies. A mobile communications device is also provided to enable the traveler to transmit his or her location in order to initiate the dispatch of a rescue services provider to transport the traveler to a location of greater safety.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: June 17, 2008
    Inventor: Donald Kaplan
  • Publication number: 20080090554
    Abstract: A method and system for providing travel services are disclosed. The method and system include a database of travel information from which information can be selectively obtained based on the traveler's circumstances. The method and system also include a system for providing counseling services and an emergency kit containing food, water and other supplies. A mobile communications device is also provided to enable the traveler to transmit his or her location in order to initiate the dispatch of a rescue services provider to transport the traveler to a location of greater safety.
    Type: Application
    Filed: October 22, 2007
    Publication date: April 17, 2008
    Inventor: Donald KAPLAN
  • Publication number: 20050234748
    Abstract: A method and system for providing travel services are disclosed. The method and system include a database of travel information from which information can be selectively obtained based on the traveler's circumstances. The method and system also include a system for providing counseling services and an emergency kit containing food, water and other supplies. A mobile communications device is also provided to enable the traveler to transmit his or her location in order to initiate the dispatch of a rescue services provider to transport the traveler to a location of greater safety.
    Type: Application
    Filed: April 16, 2004
    Publication date: October 20, 2005
    Inventor: Donald Kaplan
  • Patent number: 6312679
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: November 6, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Donald A. Kaplan, William J. Kruper, Jr., Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson
  • Patent number: 6207815
    Abstract: This invention concerns a family of chimeric antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have (1) high affinity animal VH and VL sequences which mediate TAG-72 binding and (2) human CH and CL regions. They are thought to produce significantly fewer side-effects when administered to human patients by virtue of their human CH and CL antibody domains. The nucleotide and amino acid sequences of VH&agr;TAG VH, CC46 VH, CC49H, CC83 VH, and CC92 VH, and CC49L, CC83 VL, and CC92 VL idiotype sequences are disclosed, as well as in vivo methods of treatment and diagnostic assay using these chimeric antibodies.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 27, 2001
    Assignee: The Dow Chemical Company
    Inventors: Peter S. Mezes, Brian B. Gourlie, Mark W. Rixon, Jeffrey Schlom, Donald A. Kaplan, W. H. Kerr Anderson
  • Patent number: 6177414
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: January 23, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, William J. Kruper, Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson, Donald A. Kaplan
  • Patent number: 6051225
    Abstract: This invention concerns a family of chimeric antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have (1) high affinity animal V.sub.H and V.sub.L sequences which mediate TAG-72 binding and (2) human C.sub.H and C.sub.L regions. They are thought to produce significantly fewer side-effects when administered to human patients by virtue of their human C.sub.H and C.sub.L antibody domains. The nucleotide and amino acid sequences of V.sub.H .alpha.TAG V.sub.H, CC46 V.sub.H, CC49.sub.H, CC83 V.sub.H, and CC92 V.sub.H, and CC49.sub.L, CC83 V.sub.L, and CC92 V.sub.L idiotype sequences are disclosed, as well as in vivo methods of treatment and diagnostic assay using these chimeric antibodies.
    Type: Grant
    Filed: March 31, 1993
    Date of Patent: April 18, 2000
    Assignee: The Dow Chemical Company
    Inventors: Peter S. Mezes, Brian B. Gourlie, Mark W. Rixon, Jeffrey Schlom, Donald A. Kaplan, W. H. Kerr Anderson
  • Patent number: 5993813
    Abstract: This invention concerns a family of chimeric antibodies with high affinities to a high molecular weight, tumor-associated sialylated glycoprotein antigen (TAG-72) of human origin. These antibodies have (1) high affinity animal V.sub.H and V.sub.L sequences which mediate TAG-72 binding and (2) human C.sub.H and C.sub.L regions. They are thought to produce significantly fewer side-effects when administered to human patients by virtue of their human C.sub.H and C.sub.L antibody domains. The nucleotide and amino acid sequences of V.sub.H .alpha.TAG V.sub.H, CC46 V.sub.H, CC49.sub.H, CC83 V.sub.H, and CC92 V.sub.H, and CC49.sub.L, CC83 V.sub.L, and CC92 V.sub.L idiotype sequences are disclosed, as well as in vivo methods of treatment and diagnostic assay using these chimeric antibodies.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: November 30, 1999
    Assignee: The Dow Chemical Company
    Inventors: Peter S. Mezes, Brian B. Gourlie, Mark W. Rixon, Jeffrey Schlom, Donald A. Kaplan, W. H. Kerr Anderson
  • Patent number: 5714166
    Abstract: Dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response modifier, have been prepared. The conjugate can also have a target director present, and when it is present then the carried material may be a bioactive agent. Preferred dendritic polymers are dense star polymers, which have been complexed with biological response modifiers. These conjugates and complexes have particularly advantageous properties due to their unique characteristics.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: February 3, 1998
    Assignees: The Dow Chemical Company, Dendritech Incorporated, The Regents of the University of Michigan
    Inventors: Donald A. Tomalia, James R. Baker, Roberta C. Cheng, Anna U. Bielinska, Michael J. Fazio, David M. Hedstrand, Jennifer A. Johnson, Donald A. Kaplan, deceased, Scott L. Klakamp, William J. Kruper, Jr., Jolanta Kukowska-Latallo, Bartley D. Maxon, Lars T. Piehler, Ian A. Tomlinson, Larry R. Wilson, Rui Yin, Herbert M. Brothers, II
  • Patent number: 5684004
    Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 4, 1997
    Assignee: Merrell Pharmaceuticals, Inc.
    Inventors: Donald A. Kaplan, Donald P. Matthews, Alan J. Bitonti, William A. Van Sickle
  • Patent number: 5527524
    Abstract: Dense star polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: April 5, 1993
    Date of Patent: June 18, 1996
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Larry R. Wilson, David M. Hedstrand, Ian A. Tomlinson, Michael J. Fazio, William J. Kruper, Jr., Donald A. Kaplan, Roberta C. Cheng, David S. Edwards, Chu W. Jung
  • Patent number: 5525633
    Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: June 11, 1996
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, Alan J. Bitonti, William A. Van Sickle, Donald A. Kaplan
  • Patent number: 5472693
    Abstract: The present invention discloses novel chimeric monoclonal antibodies directed against human carcinoembryonic antigen, having antigen-specific variable regions. DNA constructs for the light and heavy chain variable regions comprising the novel antibodies of the invention are also disclosed. Eukaryotic host cells capable of expression of the chimeric antibodies and comprising the novel chimeric antibody-encoding DNA constructs are also described.
    Type: Grant
    Filed: February 16, 1993
    Date of Patent: December 5, 1995
    Assignees: The Dow Chemical Company, National Institutes of Health
    Inventors: Brian B. Gourlie, Mark W. Rixon, Peter S. Mezes, Donald A. Kaplan, Jeffrey Schlom
  • Patent number: 5338532
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: February 13, 1991
    Date of Patent: August 16, 1994
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Donald A. Kaplan, William J. Kruper, Jr., Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson
  • Patent number: 4894443
    Abstract: A novel class of polypeptides of the general formula (F-(Pro).sub.n).sub.m F, wherein F represents a flexible amino acid sequence wherein each amino acid is individually selected from the group consisting of serine, glycine, and threonine, and n is an integer from 4-8 inclusive and m is an integer from 1-4 inclusive, is disclosed. Thses polypeptides are useful in the construction of conjugates between antibodies and peptide toxins. The preparation of such conjugate toxins by linking antibodies to toxin/spacer composites prepared by recombinant techniques is also disclosed.
    Type: Grant
    Filed: September 7, 1984
    Date of Patent: January 16, 1990
    Assignee: Cetus Corporation
    Inventors: Lawrence I. Greenfield, Donald A. Kaplan, Danute E. Nitecki
  • Patent number: 4853209
    Abstract: The invention concerns a method for suppressing bone marrow which comprises administering at least one bone marrow suppressing radionuclide composition selected from the group of radionuclide compositions comprised of at least one of Samarium-153, Gadolinium-519, and Holmium-166 and at least one of ethylenediaminetetramethylenephosphonic acid, diethylenetriaminepentamethylenephosphonic acid, hydroxyethylethylenediaminetrimethylenephosphonic acid, nitrilotrimethylenephosphonic acid and tris(2-aminoethyl)aminehexamethylenephosphonic acid, or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: October 27, 1987
    Date of Patent: August 1, 1989
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Kaplan, William F. Goeckeler
  • Patent number: 4603105
    Abstract: Rapid screening of a large number of organisms for variants producing particular products is accomplished using membrane plates having a predetermined molecular weight cutoff and which divide a container into two chambers. High density cellular lawns are employed in conjunction with labeled antibodies for the product of interest mixed in soft agar. The cells are subjected to viral lysis and after the plaques have reached maturity, the plates are immersed in buffer. Residual soluble labeled antibody diffuses from the agar, and immunoprecipitate of the product and the antibody may then be detected.
    Type: Grant
    Filed: May 27, 1982
    Date of Patent: July 29, 1986
    Inventor: Donald A. Kaplan
  • Patent number: 4234400
    Abstract: An improved horizontal slab gel electrophoresis apparatus having compartments for vertical wicks at each end of a removable horizontal trough. Adjacent to the vertical wicks are vertical buffer compartments with built in electrodes. A partition separates the vertical wicks from the buffer compartment and includes a slot with a silicone plug which can be removed after curing or hardening of the vertical wicks to permit communication between the buffer and the gel slab. Flow adapters and an interconnecting tube permit constant circulation of the buffer to maintain equal volume and pH. The horizontal trough has slots for insertion of combs to form up to seventy-five sample wells and additional slots at each end for sealing the end of the horizontal slab when the gel slab is removed. The apparatus includes coils in a horizontal bed or plate beneath the trough for cooling the gel slab during a run and levelling screws for levelling the horizontal trough before pouring the gel slab.
    Type: Grant
    Filed: January 26, 1979
    Date of Patent: November 18, 1980
    Assignee: The Regents of the University of California
    Inventors: Donald A. Kaplan, Gary L. Wilcox